Recent Updates
Recently added Catalysts
BSX

Boston Scientific to Participate in 2012 RBC Capital Markets' Global Healthcare Conference Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2012 RBC Capital Markets' Global Healthcare Conference on February 29 in ...

Key Takeaway: NATICK, Mass. , Feb. 22, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX ) is scheduled to participate in the 2012 RBC Capital Markets' Global Healthcare Conference on February 29 in New York . Hank Kucheman , Chief Executive Officer, and Jeff Capello , Executive V

Full Press Release Details

NATICK, Mass. , Feb. 22, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX ) is scheduled to participate in the 2012 RBC Capital Markets' Global Healthcare Conference on February 29 in New York .
Hank Kucheman , Chief Executive Officer, and Jeff Capello , Executive Vice President and Chief Financial Officer, will participate in a 25-minute question and answer session regarding the Company beginning at approximately 9:00 a.m. ET .
A live webcast of the question and answer session will be available to interested parties via Boston Scientific's website. Webcast registration is available on the Investor Relations section of the website at www.bostonscientific.com/investors . Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.
This webcast is being hosted by RBC. The replay will be archived and available at www.bostonscientific.com/investors beginning approximately one hour following the completion of the question and answer session.
About Boston Scientific
Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com .
CONTACT: Eric Olson 336-293-4393 (office) Media Relations Boston Scientific Corporation [email protected]
Lorie Fiber 310-854-8256 (office) Media Relations Weber Shandwick [email protected]
Sean Wirtjes 508-652-5305 (office) Investor Relations Boston Scientific Corporation [email protected]
SOURCE Boston Scientific Corporation

21 %

Last updated: Feb 22, 2012